- Home
- SHIP vs TARA Comparison
SHIP vs TARA Comparison
Compare SHIP & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHIP | TARA |
|---|---|---|
| Founded | 2008 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.9M | 268.5M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SHIP | TARA |
|---|---|---|
| Price | $11.97 | $4.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $17.00 | ★ $21.67 |
| AVG Volume (30 Days) | 273.3K | ★ 845.8K |
| Earning Date | 02-17-2026 | 03-10-2026 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | $20.79 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.79 | $2.77 |
| 52 Week High | $14.93 | $7.82 |
Technical Indicators
Market Signals| Indicator | SHIP | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 37.61 |
| Support Level | $7.85 | $2.96 |
| Resistance Level | $14.93 | $5.39 |
| Average True Range (ATR) | 0.63 | 0.29 |
| MACD | -0.18 | -0.03 |
| Stochastic Oscillator | 5.45 | 0.49 |
Price Performance
Historical ComparisonAbout SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).